Cargando…

PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer

Despite the expansion of PD-1 checkpoint blockade to multiple types of cancer, whether the programmed cell death 1 (PD-1) expression status on CD8+ tumour infiltrating lymphocytes (TILs) could be a prognostic factor in cervical cancer is still unclear. In this study, we performed ex vivo phenotypic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Peiwen, Li, Xi, Feng, Yaning, Cai, Hongchao, Dong, Danning, Peng, Yanchun, Yao, Xuan, Guo, Yuping, Ma, Miaomiao, Dong, Tao, Wang, Ruozheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212040/ https://www.ncbi.nlm.nih.gov/pubmed/34150643 http://dx.doi.org/10.3389/fonc.2021.678758

Ejemplares similares

Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma
por: Xie, Xiaolin, et al.
Publicado: (2023)

Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma
por: Ma, Miaomiao, et al.
Publicado: (2018)

HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer
por: Cai, Hongchao, et al.
Publicado: (2021)

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma
por: Han, S, et al.
Publicado: (2014)

Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

The difference and relationship of CD4+ and CD8+ tumour infiltrating lymphocytes in lung adenocarcinoma
por: Zhang, Chaoting, et al.
Publicado: (2019)

PD-L1 expression patterns in tumour cells and their association with CD8(+) tumour infiltrating lymphocytes in clear cell renal cell carcinoma
por: Zhu, Qian, et al.
Publicado: (2019)

Correction: Tumour-infiltrating CD8(+) lymphocytes and colorectal cancer recurrence by tumour and nodal stage
por: Glaire, Mark A., et al.
Publicado: (2019)

Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu
por: Maskey, Ninu, et al.
Publicado: (2019)

Activated innate lymphoid cell populations accumulate in human tumour tissues
por: Salimi, Maryam, et al.
Publicado: (2018)

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast
por: Rathore, Ankita Singh, et al.
Publicado: (2014)

The Predictive Value of CD3+/CD8+ Lymphocyte Infiltration and PD-L1 Expression in Colorectal Cancer
por: Liu, Jihong, et al.
Publicado: (2023)

Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma
por: Togo, Maria, et al.
Publicado: (2020)

Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer
por: Yoneda, Kazue, et al.
Publicado: (2019)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

CD8(+) Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma
por: García-Marín, Rocío, et al.
Publicado: (2020)

PD-L1, Galectin-9 and CD8(+) tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
por: Sideras, Kostandinos, et al.
Publicado: (2017)

Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance
por: Xin, Haisong, et al.
Publicado: (2023)

Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
por: Liang, Yun, et al.
Publicado: (2018)

Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma
por: Noh, Byeong-Joo, et al.
Publicado: (2020)

Radiomic Signatures Associated with CD8(+) Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study
por: Ramlee, Syafiq, et al.
Publicado: (2022)

PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells
por: Caraban, Bogdan Marian, et al.
Publicado: (2023)

PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes
por: Liu, Bin, et al.
Publicado: (2018)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

PD-L1 and tumor-infiltrating CD8(+) lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas
por: Shi, Mengwu, et al.
Publicado: (2023)

Enhanced expression of IFN- γ mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer
por: Elsässer-Beile, U, et al.
Publicado: (2000)

Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer
por: Dimitrova, Polina, et al.
Publicado: (2023)

Decreased CD8(+) Lymphocytic Infiltration in Multifocal and Multicentric Glioblastomas
por: Wang, Run, et al.
Publicado: (2021)

Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy
por: Sikandar, Bushra, et al.
Publicado: (2017)

Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma
por: de Souza, Vinícius Gonçalves, et al.
Publicado: (2022)

Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8(+) Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer
por: Munari, Enrico, et al.
Publicado: (2021)

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
por: Kitano, Atsuko, et al.
Publicado: (2017)

Expression of immune checkpoints (PD-L1 and IDO) and tumour-infiltrating lymphocytes in breast cancer
por: Alkhayyal, Noura, et al.
Publicado: (2022)

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
por: Seo, A N, et al.
Publicado: (2013)

Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors
por: Wang, Haiyue, et al.
Publicado: (2018)

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
por: Komdeur, Fenne L., et al.
Publicado: (2017)

PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors
por: Cha, Yoon Jin, et al.
Publicado: (2017)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
por: Deng, Min, et al.
Publicado: (2021)

PD-L1 Expression Correlates With Tumor Infiltrating Lymphocytes And Response To Neoadjuvant Chemotherapy In Cervical Cancer
por: Meng, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_085v7atf8k98vqmsb9v4aboki6